Superworth

Propanc Biopharma EPS PPCB

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$26.02
Latest quarter, Q4 FY26
−$1.77
Fiscal year 2026
−$26.02

Propanc Biopharma's earnings per share was −$26.02 over the twelve months to Jun 30, 2026.

In its latest quarter, Q4 FY26, it was −$1.77.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2026−$26.02n/a
FY2025−$2026.25n/a
FY2024−$114810.00n/a
FY2023−$4950000.00n/a
FY2021−$2160000000.00n/a
FY2019−$81194999999999.98n/a
FY2018−$494999999999999.88n/a
FY2017−$1709999999999999.75n/a
FY2016−$3442499999999999.50n/a
FY2015−$3749999999999999.00n/a
FY2014−$1874999999999999.50n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q4 FY26−$1.77n/a−$26.02
Q3 FY26−$7.00n/a−$33.00
Q2 FY26−$7.50n/a−$338.50
Q1 FY26−$9.75n/a−$1136.75
Q4 FY25−$8.75n/a−$2026.25
Q3 FY25−$312.50n/a−$4194.00
Q2 FY25−$805.75n/a−$17526.25
Q1 FY25−$899.25n/a−$55709.25
Q4 FY24−$2176.50n/a−$114810.00
Q3 FY24−$13644.75n/a−$442633.50
Q2 FY24−$38988.75n/a−$1058988.75
Q1 FY24−$60000.00n/a−$1815000.00

Against its peers

Companies in Healthcare nearest Propanc Biopharma's size, closest first, today.

CompanyEPS, 12 monthsGrowth
PPCBPropanc Biopharma−$26.02
OXBROXBRIDGE RE HOLDINGS$0.02
EDUCEducational Development$0.19
GTIMGood Times Restaurants$0.21+75% a year
MDRRMedalist Diversified$3.84
Peer median$0.20

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Propanc Biopharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.